表紙：マイクロアレイの世界市場の2030年までの予測：製品別、タイプ別、用途別、エンドユーザー別、地域別の世界分析

市場調査レポート

商品コード

1383449

マイクロアレイの世界市場の2030年までの予測：製品別、タイプ別、用途別、エンドユーザー別、地域別の世界分析

Microarray Market Forecasts to 2030 - Global Analysis By Product (Consumables, Instruments and Software & Services), Type, Application, End User and By Geography

出版日: 2023年11月01日
発行: Stratistics Market Research Consulting
ページ情報: 英文 200+ Pages
納期: 2～3営業日

カスタマイズ可能

価格

PDF (Single User License)

USD 4,150 609,303円

レポートPDFを1名様のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は1回のみ可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (2-5 User License)

USD 5,250 770,805円

レポートPDFを同一事業所（所在地）内の5名までご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は5回まで可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF & Excel (Site License)

USD 6,350 932,307円

レポートPDFおよびExcelを同一事業所（所在地）内のすべての方にご利用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピーは可能です。PDFおよびExcelの印刷は5回まで可能です。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

PDF & Excel (Global Site License)

USD 7,500 1,101,150円

レポートPDFおよびExcelを企業内すべての方に使用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピーは可能です。PDFおよびExcelの印刷は10回まで可能です。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=146.82円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

Stratistics MRCによると、世界のマイクロアレイ市場は2023年に47億米ドルを占め、予測期間中のCAGRは9.8%で、2030年には90億4,000万米ドルに達すると予測されています。

ゲノミクスと分子生物学において、マイクロアレイは多くの遺伝子、タンパク質、その他の物質をハイスループットで同時に調査できる効果的な技術です。同市場は、研究、診断、医薬品開発において幅広い用途を提供しており、DNA、タンパク質、組織マイクロアレイを含む多くの種類のマイクロアレイで構成されています。カスタムマイクロアレイは、複数の組織や研究者が独自の研究要件を満たすために作成しています。

2019年に英国王立化学会が発表した調査研究によると、スマートフォンに接続するポータブル蛍光マイクロアレイイメージングシステムが乳がん遺伝子発現の検出に使用されています。

さまざまな用途でマイクロアレイの利用が増加

マイクロアレイの市場は、様々な用途でマイクロアレイが使用されるようになった結果、拡大しています。より多くの科学者や組織が臨床診断、プロテオミクス、ゲノミクス、その他の分野でマイクロアレイを使用するようになり、マイクロアレイの商品やサービスに対するニーズが高まっています。最近では、医薬品開発、プロテオミクス、臨床診断、ゲノミクス、環境モニタリングなど、より多くの分野でマイクロアレイが採用されています。このような多様性により、市場は特定の業界の変化により強くなり、継続的に発展することができるようになっています。マイクロアレイは標的同定、毒性評価、バイオマーカー探索を容易にするため、医薬品開発はマイクロアレイに大きく依存しています。

次世代シーケンサー（NGS）との競合

次世代シーケンシング技術は、完全な分子およびゲノムデータを得ることができます。そのため、さまざまなアプリケーションにおいてマイクロアレイの市場シェアが低下しています。次世代シーケンサーは情報の幅が広く、ハイスループットシーケンスが可能であるため、研究者や医師が頻繁に使用しています。技術を検討する際、次世代シーケンサーはマイクロアレイよりも強力で洗練されていると思われがちです。この考え方は、研究その他の場面で次世代シーケンサーを優先してマイクロアレイを使用することを抑制し、マイクロアレイビジネスの拡大を阻害する可能性があります。

個別化医療に対する意識の高まり

個々の患者の分子プロファイリングは、薬による介入をカスタマイズする個別化医療の基盤です。各患者に特化した遺伝子・分子データを作成するためには、マイクロアレイが不可欠です。オーダーメイド医療の潜在的な利点に対する患者やヘルスケア専門家の意識の高まりが、こうした技術に対する需要の急増につながっています。オーダーメイド医療の領域では、研究者、ヘルスケア従事者、バイオテクノロジー企業間の学際的な協力が広まりつつあります。

高いメンテナンス性

マイクロアレイ技術の導入は、有資格者の不足によって妨げられる可能性があります。研究機関や臨床ラボが、技術を適切に運用するのに必要なスキルを持つスタッフを欠いている場合、マイクロアレイプラットフォームへの投資に消極的になる可能性があります。マイクロアレイデータの解析は難しく、バイオインフォマティクスの知識を必要とします。資格のある専門家の不足は、非効率的なデータ処理につながり、研究結果の先送りや誤解を招き、科学的成果を減少させる可能性があります。

COVID-19の影響

ウイルスに対する宿主応答の調査、患者の遺伝子発現変化、診断検査の作成を通じて、マイクロアレイはCOVID-19研究に貢献しました。その結果、ウイルス特異的マイクロアレイベースの検査に対する需要が増加しました。このように、パンデミックは、ワクチン開発と感染症の研究に重点を置くという、特定の地域の研究資金調達の目的に変化をもたらしました。さらに、パンデミックの急性期が過ぎれば、プロテオミクスやゲノミクスのようなライフサイエンス研究により多くの資金が投入されるようになり、マイクロアレイ市場は成長する可能性があります。

予測期間中、タンパク質マイクロアレイ分野が最大になる見込み

プロテオミクス研究において、タンパク質マイクロアレイは、タンパク質の特性、関係、役割を調べるための効果的で適応性の高いツールであるため、タンパク質マイクロアレイ分野は有利な成長を遂げると推定されます。タンパク質マイクロアレイは、遺伝子発現を調べるDNAマイクロアレイに比べ、タンパク質と他の分子の結合相互作用のハイスループット解析を可能にします。タンパク質マイクロアレイ技術の進歩により、感度、特異性、スループットが向上し、ますます洗練されたシステムが生み出されています。

予測期間中にCAGRが最も高くなると予測される疾患診断分野

遺伝子疾患、がん、感染症、染色体異常に関連する一塩基多型（SNP）は、すべてこれらのマイクロアレイを使用して発見されるため、疾患診断分野は予測期間中に最も高いCAGR成長が見込まれます。これらのマイクロアレイは、組織スライスや培養細胞を用いて、さまざまな疾患におけるタンパク質間相互作用、遺伝子発現パターン、タンパク質の局在を調べる。さらに、これらの診断用マイクロアレイは、個別化医療の時代において、患者の遺伝子プロファイルや分子プロファイルに基づいて治療計画をカスタマイズすることを可能にし、それによって市場の成長を後押ししています。

最大のシェアを占める地域

アジア太平洋地域は、最先端のヘルスケアソリューションに対する需要の高まりに加え、ゲノミクスや個別化医療の研究開発の強化が市場拡大の要因となっているため、予測期間中に最大の市場シェアを占めると予測されています。アジア太平洋地域には、マイクロアレイの研究開発に積極的に取り組んでいる学術機関、研究所、バイオテクノロジー企業があります。これには、特定の用途に合わせたマイクロアレイの作成や、さまざまな病気のバイオマーカーの同定が含まれます。

CAGRが最も高い地域：

北米は、マイクロアレイ技術の最大かつ最も発展した市場の1つであるため、予測期間中のCAGRが最も高くなると予測されています。特に米国はマイクロアレイ作成と研究の重要な中心地です。北米のマイクロアレイ市場は、マイクロアレイプラットフォーム、試薬、サービスを提供する多くの多国籍企業や地元企業によって占められています。Agilent Technologies、Illumina、Thermo Fisher Scientific、PerkinElmerなどがこの分野の主要企業であり、この地域の市場成長を牽引しています。

無料カスタマイズサービス：

本レポートをご購読のお客様には、以下の無料カスタマイズオプションのいずれかをご利用いただけます：

企業プロファイル
- 追加市場プレーヤーの包括的プロファイリング（3社まで）
- 主要企業のSWOT分析（3社まで）
地域セグメンテーション
- 顧客の関心に応じた主要国の市場推計・予測・CAGR（注：フィージビリティチェックによる）
競合ベンチマーキング
- 製品ポートフォリオ、地理的プレゼンス、戦略的提携に基づく主要企業のベンチマーキング

北米
- 米国
- カナダ
- メキシコ
欧州
- ドイツ
- 英国
- イタリア
- フランス
- スペイン
- その他の欧州
アジア太平洋
- 日本
- 中国
- インド
- オーストラリア
- ニュージーランド
- 韓国
- その他のアジア太平洋
南米
- アルゼンチン
- ブラジル
- チリ
- その他の南米
中東・アフリカ
- サウジアラビア
- アラブ首長国連邦
- カタール
- 南アフリカ
- その他の中東・アフリカ

第10章主な発展

契約、パートナーシップ、コラボレーション、合弁事業
買収と合併
新製品の発売
事業拡大
その他の主要戦略

第11章企業プロファイル

Agilent Technologies, Inc.
Thermo Fisher Scientific, Inc.
Illumina, Inc.
PerkinElmer, Inc.
Bio-Rad Laboratories
GE Healthcare
Molecular Devices, LLC
Affymetrix
Merck & Co., Inc.
Arrayit Corporation
Microarrays;Inc.
NextGen Sciences
bioMerieux SA
RayBiotech Life, Inc
PathogenDx
Diasorin Group
Schott Minifab
Full Moon Biosystems.Inc
CapitalBio Technology Co, Ltd

図表

List of Tables

Table 1 Global Microarray Market Outlook, By Region (2021-2030) ($MN)
Table 2 Global Microarray Market Outlook, By Product (2021-2030) ($MN)
Table 3 Global Microarray Market Outlook, By Consumables (2021-2030) ($MN)
Table 4 Global Microarray Market Outlook, By Instruments (2021-2030) ($MN)
Table 5 Global Microarray Market Outlook, By Software & Services (2021-2030) ($MN)
Table 6 Global Microarray Market Outlook, By Type (2021-2030) ($MN)
Table 7 Global Microarray Market Outlook, By Protein Microarrays (2021-2030) ($MN)
Table 8 Global Microarray Market Outlook, By DNA Microarrays (2021-2030) ($MN)
Table 9 Global Microarray Market Outlook, By Other Microarrays (2021-2030) ($MN)
Table 10 Global Microarray Market Outlook, By Application (2021-2030) ($MN)
Table 11 Global Microarray Market Outlook, By Drug Discovery (2021-2030) ($MN)
Table 12 Global Microarray Market Outlook, By Diseases Diagnostics (2021-2030) ($MN)
Table 13 Global Microarray Market Outlook, By Research Applications (2021-2030) ($MN)
Table 14 Global Microarray Market Outlook, By Agriculture (2021-2030) ($MN)
Table 15 Global Microarray Market Outlook, By Other Applications (2021-2030) ($MN)
Table 16 Global Microarray Market Outlook, By End User (2021-2030) ($MN)
Table 17 Global Microarray Market Outlook, By Pharmaceutical & Biotechnology Companies (2021-2030) ($MN)
Table 18 Global Microarray Market Outlook, By Research & Academic Institutes (2021-2030) ($MN)
Table 19 Global Microarray Market Outlook, By Diagnostic Laboratories (2021-2030) ($MN)
Table 20 Global Microarray Market Outlook, By Other End Users (2021-2030) ($MN)
Table 21 North America Microarray Market Outlook, By Country (2021-2030) ($MN)
Table 22 North America Microarray Market Outlook, By Product (2021-2030) ($MN)
Table 23 North America Microarray Market Outlook, By Consumables (2021-2030) ($MN)
Table 24 North America Microarray Market Outlook, By Instruments (2021-2030) ($MN)
Table 25 North America Microarray Market Outlook, By Software & Services (2021-2030) ($MN)
Table 26 North America Microarray Market Outlook, By Type (2021-2030) ($MN)
Table 27 North America Microarray Market Outlook, By Protein Microarrays (2021-2030) ($MN)
Table 28 North America Microarray Market Outlook, By DNA Microarrays (2021-2030) ($MN)
Table 29 North America Microarray Market Outlook, By Other Microarrays (2021-2030) ($MN)
Table 30 North America Microarray Market Outlook, By Application (2021-2030) ($MN)
Table 31 North America Microarray Market Outlook, By Drug Discovery (2021-2030) ($MN)
Table 32 North America Microarray Market Outlook, By Diseases Diagnostics (2021-2030) ($MN)
Table 33 North America Microarray Market Outlook, By Research Applications (2021-2030) ($MN)
Table 34 North America Microarray Market Outlook, By Agriculture (2021-2030) ($MN)
Table 35 North America Microarray Market Outlook, By Other Applications (2021-2030) ($MN)
Table 36 North America Microarray Market Outlook, By End User (2021-2030) ($MN)
Table 37 North America Microarray Market Outlook, By Pharmaceutical & Biotechnology Companies (2021-2030) ($MN)
Table 38 North America Microarray Market Outlook, By Research & Academic Institutes (2021-2030) ($MN)
Table 39 North America Microarray Market Outlook, By Diagnostic Laboratories (2021-2030) ($MN)
Table 40 North America Microarray Market Outlook, By Other End Users (2021-2030) ($MN)
Table 41 Europe Microarray Market Outlook, By Country (2021-2030) ($MN)
Table 42 Europe Microarray Market Outlook, By Product (2021-2030) ($MN)
Table 43 Europe Microarray Market Outlook, By Consumables (2021-2030) ($MN)
Table 44 Europe Microarray Market Outlook, By Instruments (2021-2030) ($MN)
Table 45 Europe Microarray Market Outlook, By Software & Services (2021-2030) ($MN)
Table 46 Europe Microarray Market Outlook, By Type (2021-2030) ($MN)
Table 47 Europe Microarray Market Outlook, By Protein Microarrays (2021-2030) ($MN)
Table 48 Europe Microarray Market Outlook, By DNA Microarrays (2021-2030) ($MN)
Table 49 Europe Microarray Market Outlook, By Other Microarrays (2021-2030) ($MN)
Table 50 Europe Microarray Market Outlook, By Application (2021-2030) ($MN)
Table 51 Europe Microarray Market Outlook, By Drug Discovery (2021-2030) ($MN)
Table 52 Europe Microarray Market Outlook, By Diseases Diagnostics (2021-2030) ($MN)
Table 53 Europe Microarray Market Outlook, By Research Applications (2021-2030) ($MN)
Table 54 Europe Microarray Market Outlook, By Agriculture (2021-2030) ($MN)
Table 55 Europe Microarray Market Outlook, By Other Applications (2021-2030) ($MN)
Table 56 Europe Microarray Market Outlook, By End User (2021-2030) ($MN)
Table 57 Europe Microarray Market Outlook, By Pharmaceutical & Biotechnology Companies (2021-2030) ($MN)
Table 58 Europe Microarray Market Outlook, By Research & Academic Institutes (2021-2030) ($MN)
Table 59 Europe Microarray Market Outlook, By Diagnostic Laboratories (2021-2030) ($MN)
Table 60 Europe Microarray Market Outlook, By Other End Users (2021-2030) ($MN)
Table 61 Asia Pacific Microarray Market Outlook, By Country (2021-2030) ($MN)
Table 62 Asia Pacific Microarray Market Outlook, By Product (2021-2030) ($MN)
Table 63 Asia Pacific Microarray Market Outlook, By Consumables (2021-2030) ($MN)
Table 64 Asia Pacific Microarray Market Outlook, By Instruments (2021-2030) ($MN)
Table 65 Asia Pacific Microarray Market Outlook, By Software & Services (2021-2030) ($MN)
Table 66 Asia Pacific Microarray Market Outlook, By Type (2021-2030) ($MN)
Table 67 Asia Pacific Microarray Market Outlook, By Protein Microarrays (2021-2030) ($MN)
Table 68 Asia Pacific Microarray Market Outlook, By DNA Microarrays (2021-2030) ($MN)
Table 69 Asia Pacific Microarray Market Outlook, By Other Microarrays (2021-2030) ($MN)
Table 70 Asia Pacific Microarray Market Outlook, By Application (2021-2030) ($MN)
Table 71 Asia Pacific Microarray Market Outlook, By Drug Discovery (2021-2030) ($MN)
Table 72 Asia Pacific Microarray Market Outlook, By Diseases Diagnostics (2021-2030) ($MN)
Table 73 Asia Pacific Microarray Market Outlook, By Research Applications (2021-2030) ($MN)
Table 74 Asia Pacific Microarray Market Outlook, By Agriculture (2021-2030) ($MN)
Table 75 Asia Pacific Microarray Market Outlook, By Other Applications (2021-2030) ($MN)
Table 76 Asia Pacific Microarray Market Outlook, By End User (2021-2030) ($MN)
Table 77 Asia Pacific Microarray Market Outlook, By Pharmaceutical & Biotechnology Companies (2021-2030) ($MN)
Table 78 Asia Pacific Microarray Market Outlook, By Research & Academic Institutes (2021-2030) ($MN)
Table 79 Asia Pacific Microarray Market Outlook, By Diagnostic Laboratories (2021-2030) ($MN)
Table 80 Asia Pacific Microarray Market Outlook, By Other End Users (2021-2030) ($MN)
Table 81 South America Microarray Market Outlook, By Country (2021-2030) ($MN)
Table 82 South America Microarray Market Outlook, By Product (2021-2030) ($MN)
Table 83 South America Microarray Market Outlook, By Consumables (2021-2030) ($MN)
Table 84 South America Microarray Market Outlook, By Instruments (2021-2030) ($MN)
Table 85 South America Microarray Market Outlook, By Software & Services (2021-2030) ($MN)
Table 86 South America Microarray Market Outlook, By Type (2021-2030) ($MN)
Table 87 South America Microarray Market Outlook, By Protein Microarrays (2021-2030) ($MN)
Table 88 South America Microarray Market Outlook, By DNA Microarrays (2021-2030) ($MN)
Table 89 South America Microarray Market Outlook, By Other Microarrays (2021-2030) ($MN)
Table 90 South America Microarray Market Outlook, By Application (2021-2030) ($MN)
Table 91 South America Microarray Market Outlook, By Drug Discovery (2021-2030) ($MN)
Table 92 South America Microarray Market Outlook, By Diseases Diagnostics (2021-2030) ($MN)
Table 93 South America Microarray Market Outlook, By Research Applications (2021-2030) ($MN)
Table 94 South America Microarray Market Outlook, By Agriculture (2021-2030) ($MN)
Table 95 South America Microarray Market Outlook, By Other Applications (2021-2030) ($MN)
Table 96 South America Microarray Market Outlook, By End User (2021-2030) ($MN)
Table 97 South America Microarray Market Outlook, By Pharmaceutical & Biotechnology Companies (2021-2030) ($MN)
Table 98 South America Microarray Market Outlook, By Research & Academic Institutes (2021-2030) ($MN)
Table 99 South America Microarray Market Outlook, By Diagnostic Laboratories (2021-2030) ($MN)
Table 100 South America Microarray Market Outlook, By Other End Users (2021-2030) ($MN)
Table 101 Middle East & Africa Microarray Market Outlook, By Country (2021-2030) ($MN)
Table 102 Middle East & Africa Microarray Market Outlook, By Product (2021-2030) ($MN)
Table 103 Middle East & Africa Microarray Market Outlook, By Consumables (2021-2030) ($MN)
Table 104 Middle East & Africa Microarray Market Outlook, By Instruments (2021-2030) ($MN)
Table 105 Middle East & Africa Microarray Market Outlook, By Software & Services (2021-2030) ($MN)
Table 106 Middle East & Africa Microarray Market Outlook, By Type (2021-2030) ($MN)
Table 107 Middle East & Africa Microarray Market Outlook, By Protein Microarrays (2021-2030) ($MN)
Table 108 Middle East & Africa Microarray Market Outlook, By DNA Microarrays (2021-2030) ($MN)
Table 109 Middle East & Africa Microarray Market Outlook, By Other Microarrays (2021-2030) ($MN)
Table 110 Middle East & Africa Microarray Market Outlook, By Application (2021-2030) ($MN)
Table 111 Middle East & Africa Microarray Market Outlook, By Drug Discovery (2021-2030) ($MN)
Table 112 Middle East & Africa Microarray Market Outlook, By Diseases Diagnostics (2021-2030) ($MN)
Table 113 Middle East & Africa Microarray Market Outlook, By Research Applications (2021-2030) ($MN)
Table 114 Middle East & Africa Microarray Market Outlook, By Agriculture (2021-2030) ($MN)
Table 115 Middle East & Africa Microarray Market Outlook, By Other Applications (2021-2030) ($MN)
Table 116 Middle East & Africa Microarray Market Outlook, By End User (2021-2030) ($MN)
Table 117 Middle East & Africa Microarray Market Outlook, By Pharmaceutical & Biotechnology Companies (2021-2030) ($MN)
Table 118 Middle East & Africa Microarray Market Outlook, By Research & Academic Institutes (2021-2030) ($MN)
Table 119 Middle East & Africa Microarray Market Outlook, By Diagnostic Laboratories (2021-2030) ($MN)
Table 120 Middle East & Africa Microarray Market Outlook, By Other End Users (2021-2030) ($MN)

Product Code: SMRC24297

According to Stratistics MRC, the Global Microarray Market is accounted for $4.70 billion in 2023 and is expected to reach $9.04 billion by 2030 growing at a CAGR of 9.8% during the forecast period. In genomics and molecular biology, microarrays are an effective technology that allow for the high-throughput, simultaneous investigation of many genes, proteins, or other substances. The market offers a broad variety of applications in research, diagnostics, and drug development and comprises many types of microarrays, including DNA, protein, and tissue microarrays. Custom microarrays are created by several organizations and researchers to meet their unique research requirements.

According to a research study published by the Royal Society of Chemistry in 2019, a portable fluorescence microarray imaging system that connects to a smartphone has been used for the detection of breast cancer gene expression.

Market Dynamics:

Driver:

Rise in the usage of microarrays in various applications

The market for microarrays has grown as a result of the growing use of microarrays in various applications. The need for microarray goods and services has increased as more scientists and organizations use them for clinical diagnostics, proteomics, genomics, and other areas. These days, microarrays are employed in many more fields, such as drug development, proteomics, clinical diagnostics, genomics, and environmental monitoring due to this diversity, the market is now more resilient to changes in certain industries and has been able to develop continuously. Drug development relies heavily on microarrays because they make target identification, toxicity assessment, and biomarker discovery easier.

Restraint:

Competition from next-generation sequencing (NGS)

Next-generation sequencing technologies can give complete molecular and genomic data; they have become more and more popular. They have so reduced microarrays' market share across a range of applications. Because of Next-generation sequencing breadth of information and high-throughput sequencing capabilities, researchers and physicians frequently use it. When considering technologies, it is frequently thought to be more potent and sophisticated than microarrays. This idea may discourage the use of microarrays in favour of next-generation sequencing in research and other settings, which might stunt the expansion of the microarray business.

Opportunity:

Growing awareness regarding personalized medicines

Molecular profiling of individual patients is the foundation of personalized medicine, which customizes medicinal interventions. In order to produce genetic and molecular data particular to each patient, microarrays are essential. The growing awareness among patients and healthcare professionals of the potential advantages of customized medicine has led to a surge in demand for these technologies. In the realm of customized medicine, interdisciplinary collaboration between researchers, healthcare practitioners, and biotechnology businesses is becoming more widespread.

Threat:

High maintenance

Microarray technology adoption may be hindered by the lack of qualified workers. If research organizations and clinical labs lack the staff with the necessary skills to properly run the technology, they can be reluctant to invest in microarray platforms. The analysis of microarray data might be challenging and call for bioinformatics knowledge. A shortage of qualified experts might lead to ineffective data processing, which would postpone research results, misunderstand them, and decrease scientific output thus hampering the market growth.

COVID-19 Impact

Through the investigation of host responses to the virus, patient gene expression alterations, and the creation of diagnostic tests, microarrays contributed to COVID-19 research. As a result, there was a rise in demand for virus-specific microarray-based tests. Thus, the pandemic caused changes in certain regions' objectives for financing research, with an emphasis on developing vaccines and researching infectious diseases. Furthermore, the market for microarrays may grow if more money is invested in life sciences research, like as proteomics and genomics, once the pandemic's acute phase has passed.

The protein microarrays segment is expected to be the largest during the forecast period

The protein microarrays segment is estimated to have a lucrative growth, as these proteomics research, protein microarrays are an effective and adaptable tool for examining the characteristics, relationships, and roles of proteins. Protein microarrays enable high-throughput analysis of the binding interactions of proteins and other molecules, much to DNA microarrays, which are used to examine gene expression. The advancement of protein microarray technology has produced increasingly sophisticated systems with improved sensitivity, specificity, and throughput.

The diseases diagnostics segment is expected to have the highest CAGR during the forecast period

The diseases diagnostics segment is anticipated to witness the highest CAGR growth during the forecast period, because the single nucleotide polymorphisms (SNPs) linked to genetic disorders, cancer, and infectious illnesses, as well as chromosomal abnormalities, are all found using these microarrays. These microarrays investigate protein-protein interactions, gene expression patterns, and protein localization in a variety of disorders using tissue slices or cultured cells. Moreover these diagnostic microarrays allow for customized treatment plans based on a patient's genetic or molecular profile in the age of personalized medicine thereby boosting the market growth.

Region with largest share:

Asia Pacific is projected to hold the largest market share during the forecast period owing to the rising demand for cutting-edge healthcare solutions as well as enhanced genomics and personalized medicine research and development efforts are responsible for this expansion. The Asia Pacific area is home to several academic institutions, research labs, and biotechnology corporations that are actively involved in microarray research and development. This involves the creation of personalized microarrays for particular uses and the identification of biomarkers for a range of illnesses.

Region with highest CAGR:

North America is projected to have the highest CAGR over the forecast period; owing to one of the biggest and most developed markets for microarray technology. Particularly, the US is a significant centre for microarray creation and research. The North American microarray market is occupied by a number of multinational and local businesses that offer microarray platforms, reagents, and services. Agilent Technologies, Illumina, Thermo Fisher Scientific, PerkinElmer, and many more are some of the major companies in this sector are driving the market growth in this region.

Key players in the market

Some of the key players profiled in the Microarray Market include: Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., Illumina, Inc., PerkinElmer, Inc., Bio-Rad Laboratories, GE Healthcare, Molecular Devices, LLC, Affymetrix, Merck & Co., Inc., Arrayit Corporation, Microarrays; Inc., NextGen Sciences, bioMerieux SA, RayBiotech Life, Inc, PathogenDx, Diasorin Group, Schott Minifab, Full Moon Biosystems.Inc and CapitalBio Technology Co, Ltd

Key Developments:

In October 2023, Thermo Fisher Scientific, the world leader in serving science, has introduced the Thermo Scientific™ Meridian™ EX System an electron-beam-based failure analysis solution designed to enable precise fault localization on advanced semiconductor logic technologies.

In October 2023, Thermo Fisher Scientific announced a companion diagnostic (CDx) partnership with Boehringer Ingelheim. Through this collaboration, the companies will work to develop CDx tests to help identify patients with non-small cell lung cancer (NSCLC) with specific genomic mutations.

In September 2023, Agilent Technologies Inc recently signed a Research Collaboration Agreement (RCA) with the National Cancer Centre Singapore (NCCS) outlining their collaboration to accelerate translational cancer research on the genomic landscape of Asian-prevalent cancers over the next two years.

Products Covered:

Consumables
Instruments
Software & Services

Types Covered:

Protein Microarrays
DNA Microarrays
Other Microarrays

Applications Covered:

Drug Discovery
Diseases Diagnostics
Research Applications
Agriculture
Other Applications

End Users Covered:

Pharmaceutical & Biotechnology Companies
Research & Academic Institutes
Diagnostic Laboratories
Other End Users

Regions Covered:

North America
- US
- Canada
- Mexico
Europe
- Germany
- UK
- Italy
- France
- Spain
- Rest of Europe
Asia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- South Korea
- Rest of Asia Pacific
South America
- Argentina
- Brazil
- Chile
- Rest of South America
Middle East & Africa
- Saudi Arabia
- UAE
- Qatar
- South Africa
- Rest of Middle East & Africa

What our report offers:

Market share assessments for the regional and country-level segments
Strategic recommendations for the new entrants
Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
Strategic recommendations in key business segments based on the market estimations
Competitive landscaping mapping the key common trends
Company profiling with detailed strategies, financials, and recent developments
Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

Company Profiling
- Comprehensive profiling of additional market players (up to 3)
- SWOT Analysis of key players (up to 3)
Regional Segmentation
- Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
Competitive Benchmarking
- Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

1 Executive Summary

2 Preface

2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
- 2.4.1 Data Mining
- 2.4.2 Data Analysis
- 2.4.3 Data Validation
- 2.4.4 Research Approach
2.5 Research Sources
- 2.5.1 Primary Research Sources
- 2.5.2 Secondary Research Sources
- 2.5.3 Assumptions

3 Market Trend Analysis

3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Application Analysis
3.8 End User Analysis
3.9 Emerging Markets
3.10 Impact of Covid-19

4 Porters Five Force Analysis

4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Microarray Market, By Product

5.1 Introduction
5.2 Consumables
5.3 Instruments
5.4 Software & Services

6 Global Microarray Market, By Type

6.1 Introduction
6.2 Protein Microarrays
6.3 DNA Microarrays
6.4 Other Microarrays

7 Global Microarray Market, By Application

7.1 Introduction
7.2 Drug Discovery
7.3 Diseases Diagnostics
7.4 Research Applications
7.5 Agriculture
7.6 Other Applications

8 Global Microarray Market, By End User

8.1 Introduction
8.2 Pharmaceutical & Biotechnology Companies
8.3 Research & Academic Institutes
8.4 Diagnostic Laboratories
8.5 Other End Users

9 Global Microarray Market, By Geography

9.1 Introduction
9.2 North America
- 9.2.1 US
- 9.2.2 Canada
- 9.2.3 Mexico
9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 Italy
- 9.3.4 France
- 9.3.5 Spain
- 9.3.6 Rest of Europe
9.4 Asia Pacific
- 9.4.1 Japan
- 9.4.2 China
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 New Zealand
- 9.4.6 South Korea
- 9.4.7 Rest of Asia Pacific
9.5 South America
- 9.5.1 Argentina
- 9.5.2 Brazil
- 9.5.3 Chile
- 9.5.4 Rest of South America
9.6 Middle East & Africa
- 9.6.1 Saudi Arabia
- 9.6.2 UAE
- 9.6.3 Qatar
- 9.6.4 South Africa
- 9.6.5 Rest of Middle East & Africa

10 Key Developments

10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies

11 Company Profiling

11.1 Agilent Technologies, Inc.
11.2 Thermo Fisher Scientific, Inc.
11.3 Illumina, Inc.
11.4 PerkinElmer, Inc.
11.5 Bio-Rad Laboratories
11.6 GE Healthcare
11.7 Molecular Devices, LLC
11.8 Affymetrix
11.9 Merck & Co., Inc.
11.10 Arrayit Corporation
11.11 Microarrays; Inc.
11.12 NextGen Sciences
11.13 bioMerieux SA
11.14 RayBiotech Life, Inc
11.15 PathogenDx
11.16 Diasorin Group
11.17 Schott Minifab
11.18 Full Moon Biosystems.Inc
11.19 CapitalBio Technology Co, Ltd